NCT05238597 - A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease | Biotech Hunter

Enrollment

207

Participants

Timeline

Start Date

January 25, 2022

Primary Completion Date

January 24, 2023

Study Completion Date

January 24, 2023

Conditions

Dry Eye Disease

Interventions

DRUG

A197 Ophthalmic Solution

DRUG

A197 Vehicle Control

DRUG

Active Comparator

Trial Locations (24)

16066

Aramis Site 123, Cranberry Township

27529

Aramis Site 110, Garner

28150

Aramis Site 122, Shelby

32204

Aramis Site 112, Jacksonville

33484

Aramis Site 101, Delray Beach

33773

Aramis Site 117, Largo

35233

Aramis Site 113, Birmingham

37072

Aramis Site 115, Goodlettsville

38119

Aramis Site 103, Memphis

41017

Aramis Site 118, Edgewood

45040

Aramis Site 119, Mason

63128

Aramis Site 111, St Louis

64111

Aramis Site 114, Kansas City

78215

Aramis Site 105, San Antonio

78738

Aramis Site 104, Lakeway

89119

Aramis Site 108, Las Vegas

90013

Aramis Site 124, Los Angeles

90805

Aramis Site 106, Long Beach

92562

Aramis Site 107, Murrieta

92663

Aramis Site 102, Newport Beach

92843

Aramis Site 121, Garden Grove

94954

Aramis Site 116, Petaluma

95670

Aramis Site 109, Rancho Cordova

95817

Aramis Site 120, Glendale